Papaya improves non-alcoholic fatty liver disease in obese rats by attenuating oxidative stress, inflammation and lipogenic gene expression

Figure 3 Effects of papaya on proinflammatory cytokines in liver tissue. A: Tumour necrosis factor-α (TNF-α) in the liver; B: Interleukin 6 (IL-6) in the liver. Data are expressed as mean ± SE of the mean (n = 6-7). ^aP < 0.05, ^bP < 0.01 vs control (C), and ^dP < 0.05 vs high fat diet (HFD) group. HFH: High fat diet treated with 1 mL of papaya juice/100 g body weight; HFL: High fat diet treated with 0.5 mL of papaya juice/100 g body weight.